Literature DB >> 26185601

Fetal programming of polycystic ovary syndrome.

Esra Bahar Gur1, Muammer Karadeniz1, Guluzar Arzu Turan1.   

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder that affects up to 6.8% of reproductive age women. Experimental research and clinical observations suggest that PCOS may originate in the very early stages of development, possibly even during intrauterine life. This suggests that PCOS is either genetically-transmitted or is due to epigenetic alterations that develop in the intrauterine microenvironment. Although familial cases support the role of genetic factors, no specific genetic pattern has been defined in PCOS. Several candidate genes have been implicated in its pathogenesis, but none can specifically be implicated in PCOS development. Hypotheses based on the impact of the intrauterine environment on PCOS development can be grouped into two categories. The first is the "thrifty" phenotype hypothesis, which states that intrauterine nutritional restriction in fetuses causes decreased insulin secretion and, as a compensatory mechanism, insulin resistance. Additionally, an impaired nutritional environment can affect the methylation of some specific genes, which can also trigger PCOS. The second hypothesis postulates that fetal exposure to excess androgen can induce changes in differentiating tissues, causing the PCOS phenotype to develop in adult life. This review aimed to examine the role of fetal programming in development of PCOS.

Entities:  

Keywords:  Androgens; Fetal programming; Genetic; Intrauterine growth retardation; Polycystic ovary syndrome

Year:  2015        PMID: 26185601      PMCID: PMC4499527          DOI: 10.4239/wjd.v6.i7.936

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  57 in total

Review 1.  Candidate genes in polycystic ovary syndrome.

Authors:  S Franks; N Gharani; M McCarthy
Journal:  Hum Reprod Update       Date:  2001 Jul-Aug       Impact factor: 15.610

2.  Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.

Authors:  L Ibañez; J E Hall; N Potau; A Carrascosa; N Prat; A E Taylor
Journal:  J Clin Endocrinol Metab       Date:  1996-11       Impact factor: 5.958

3.  Modulation of aromatase and P450 cholesterol side-chain cleavage enzyme activities of human placental cytotrophoblasts by insulin and insulin-like growth factor I.

Authors:  J E Nestler
Journal:  Endocrinology       Date:  1987-11       Impact factor: 4.736

4.  Maternal insulin resistance and preeclampsia.

Authors:  John C Hauth; Rebecca G Clifton; James M Roberts; Leslie Myatt; Catherine Y Spong; Kenneth J Leveno; Michael W Varner; Ronald J Wapner; John M Thorp; Brian M Mercer; Alan M Peaceman; Susan M Ramin; Marshall W Carpenter; Philip Samuels; Anthony Sciscione; Jorge E Tolosa; George Saade; Yoram Sorokin; Garland D Anderson
Journal:  Am J Obstet Gynecol       Date:  2011-04       Impact factor: 8.661

5.  Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator.

Authors:  Eileen M Foecking; Marta Szabo; Neena B Schwartz; Jon E Levine
Journal:  Biol Reprod       Date:  2005-03-02       Impact factor: 4.285

6.  To determine whether first-degree male relatives of women with polycystic ovary syndrome are at higher risk of developing cardiovascular disease and type II diabetes mellitus.

Authors:  A Hunter; S Vimplis; A Sharma; N Eid; W Atiomo
Journal:  J Obstet Gynaecol       Date:  2007-08       Impact factor: 1.246

7.  Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth.

Authors:  L Ibáñez; N Potau; I Francois; F de Zegher
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

8.  Broad clinical spectrum in Silver-Russell syndrome and consequences for genetic testing in growth retardation.

Authors:  Thomas Eggermann; Daniela Gonzalez; Sabrina Spengler; Mine Arslan-Kirchner; Gerhard Binder; Nadine Schönherr
Journal:  Pediatrics       Date:  2009-04-13       Impact factor: 7.124

9.  Reduced intrafollicular androstenedione and estradiol levels in early-treated prenatally androgenized female rhesus monkeys receiving follicle-stimulating hormone therapy for in vitro fertilization.

Authors:  Daniel A Dumesic; R Dee Schramm; Ian M Bird; Eric Peterson; Ann Marie Paprocki; Rao Zhou; David H Abbott
Journal:  Biol Reprod       Date:  2003-06-11       Impact factor: 4.285

10.  DHEA-S-loading test in cases of intrauterine growth retardation: relationship between the pattern of the maternal plasma metabolites and the fetoplacental dysfunction.

Authors:  G Tanguy; H J Thoumsin; J R Zorn; L Cedard
Journal:  Gynecol Obstet Invest       Date:  1981       Impact factor: 2.031

View more
  11 in total

1.  Upregulated Ribosomal Pathway Impairs Follicle Development in a Polycystic Ovary Syndrome Mouse Model: Differential Gene Expression Analysis of Oocytes.

Authors:  Natsuki Nakanishi; Satoko Osuka; Tomohiro Kono; Hisato Kobayashi; Shinya Ikeda; Bayasula Bayasula; Reina Sonehara; Mayuko Murakami; Sayako Yoshita; Natsuki Miyake; Ayako Muraoka; Yukiyo Kasahara; Tomohiko Murase; Tomoko Nakamura; Maki Goto; Akira Iwase; Hiroaki Kajiyama
Journal:  Reprod Sci       Date:  2022-10-04       Impact factor: 2.924

2.  Causality of anthropometric markers associated with polycystic ovarian syndrome: Findings of a Mendelian randomization study.

Authors:  Kushan De Silva; Ryan T Demmer; Daniel Jönsson; Aya Mousa; Helena Teede; Andrew Forbes; Joanne Enticott
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

3.  DNA methylation in promoter regions of genes involved in the reproductive and metabolic function of children born to women with PCOS.

Authors:  Bárbara Echiburú; Fermín Milagro; Nicolás Crisosto; Francisco Pérez-Bravo; Cristian Flores; Ana Arpón; Francisca Salas-Pérez; Sergio E Recabarren; Teresa Sir-Petermann; Manuel Maliqueo
Journal:  Epigenetics       Date:  2020-04-20       Impact factor: 4.528

Review 4.  Polycystic Ovary Syndrome: the Epigenetics Behind the Disease.

Authors:  Matheus Credendio Eiras; Daniel Pascoalino Pinheiro; Kalil Andrade Mubarac Romcy; Rui Alberto Ferriani; Rosana Maria Dos Reis; Cristiana Libardi Miranda Furtado
Journal:  Reprod Sci       Date:  2021-04-07       Impact factor: 3.060

Review 5.  The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art.

Authors:  Vincenzina Bruni; Anna Capozzi; Stefano Lello
Journal:  Reprod Sci       Date:  2021-03-11       Impact factor: 3.060

6.  Epigenetic modification of long interspersed elements-1 in cumulus cells of mature and immature oocytes from patients with polycystic ovary syndrome.

Authors:  Kamthorn Pruksananonda; Artisa Wasinarom; Wisan Sereepapong; Porntip Sirayapiwat; Prakasit Rattanatanyong; Apiwat Mutirangura
Journal:  Clin Exp Reprod Med       Date:  2016-06-23

7.  Shaoyao-Gancao Decoction alleviated hyperandrogenism in a letrozole-induced rat model of polycystic ovary syndrome by inhibition of NF-κB activation.

Authors:  Yun-Yun Shao; Zhuang-Peng Chang; Yao Cheng; Xin-Chun Wang; Jing-Ping Zhang; Xiao-Juan Feng; Yi-Ting Guo; Jun-Jin Liu; Rui-Gang Hou
Journal:  Biosci Rep       Date:  2019-01-11       Impact factor: 3.840

8.  National and regional trends in the prevalence of polycystic ovary syndrome since 1990 within Europe: the modeled estimates from the Global Burden of Disease Study 2016.

Authors:  Tomasz Miazgowski; Ira Martopullo; Justyna Widecka; Bartosz Miazgowski; Agnieszka Brodowska
Journal:  Arch Med Sci       Date:  2019-08-06       Impact factor: 3.318

9.  Evaluation of CAG repeat length in the androgen receptor gene and polycystic ovary syndrome risk in Iranian women: A case-control study.

Authors:  Hamideh Arasteh; Fatemeh Araste; Mohammad Hasan Sheikhha; Seyyed Mehdi Kalantar; Ehsan Farashahi Yazd; Hamid Reza Ashrafzadeh; Nasrin Ghasemi
Journal:  Int J Reprod Biomed       Date:  2022-04-21

Review 10.  Why are women with polycystic ovary syndrome obese?

Authors:  T M Barber
Journal:  Br Med Bull       Date:  2022-09-22       Impact factor: 5.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.